Medpace Holdings
MEDP
Medpace Holdings (MEDP) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $4.25
- EPS estimate
- $3.98
- EPS surprise
- +6.83%
- Revenue surprise
- +2.58%
- Revenue
- $707.3M
- Revenue estimate
- $689.5M
- Reported
- Jul 22, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 22, 2026 | $3.98 | $4.25 | +6.83% | $707.3M | SEC |
| Q1 2026 | Apr 22, 2026 | $3.92 | $4.28 | +9.17% | $706.6M | SEC |
| Q4 2025 | Feb 9, 2026 | $4.19 | $4.67 | +11.58% | $708.5M | SEC |
| Q3 2025 | Oct 22, 2025 | $3.53 | $3.86 | +9.20% | $659.9M | SEC |
| Q2 2025 | Jul 21, 2025 | $2.98 | $3.10 | +3.94% | $603.3M | SEC |
| Q1 2025 | Apr 21, 2025 | $3.06 | $3.67 | +19.95% | $558.6M | SEC |
| Q4 2024 | Feb 10, 2025 | $2.94 | $3.67 | +24.87% | $536.6M | SEC |
| Q3 2024 | Oct 21, 2024 | $2.77 | $3.01 | +8.64% | $533.3M | SEC |
| Q2 2024 | Jul 22, 2024 | $2.54 | $2.75 | +8.33% | $528.1M | SEC |
| Q1 2024 | Apr 22, 2024 | $2.47 | $3.20 | +29.79% | $511.0M | SEC |
| Q4 2023 | Feb 12, 2024 | $2.22 | $2.46 | +10.78% | $498.4M | SEC |
| Q3 2023 | Oct 23, 2023 | $2.05 | $2.22 | +8.49% | $492.5M | SEC |
| Q2 2023 | Jul 24, 2023 | $1.91 | $1.93 | +0.81% | $460.9M | SEC |
| Q1 2023 | Apr 24, 2023 | $1.82 | $2.27 | +25.06% | $434.1M | SEC |
| Q4 2022 | Feb 13, 2023 | $1.79 | $2.12 | +18.73% | $394.1M | SEC |
| Q3 2022 | Oct 24, 2022 | $1.47 | $2.05 | +39.03% | $383.7M | SEC |
| Q2 2022 | Jul 25, 2022 | $1.31 | $1.46 | +11.28% | $351.2M | SEC |
| Q1 2022 | Apr 25, 2022 | $1.26 | $1.69 | +34.13% | $330.9M | SEC |
| Q4 2021 | Feb 14, 2022 | $1.25 | $1.32 | +5.60% | $308.6M | SEC |
| Q3 2021 | Oct 25, 2021 | $1.08 | $1.29 | +19.44% | $295.6M | SEC |
Quarterly revenue
Frequently asked questions
When did Medpace Holdings (MEDP) last report earnings?
Medpace Holdings last reported on Jul 22, 2026, covering fiscal Q2 2026.
Did MEDP beat earnings estimates?
Yes. Medpace Holdings reported EPS of $4.25 for Q2 2026 against a $3.98 estimate — a 6.83% beat.
How much revenue did MEDP report last quarter?
Medpace Holdings reported $707.3M in revenue for Q2 2026, against a consensus estimate of $689.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.